In the latest quarter, 11 analysts provided ratings for Edwards Lifesciences (NYSE:EW), showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 5 | 5 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 2 | 3 | 0 | 0 |
| 2M Ago | 0 | 2 | 2 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $96.45, a high estimate of $105.00, and a low estimate of $85.00. Witnessing a positive shift, the current average has risen by 5.25% from the previous average price target of $91.64.
Interpreting Analyst Ratings: A Closer Look
The standing of Edwards Lifesciences among financial experts becomes clear with a thorough...
Login or create a forever free account to read this news
Sign up/Log in